Literature DB >> 1338427

Hormones and immune responsiveness in chronic lymphocytic leukemia.

H Everaus1.   

Abstract

Chronic lymphocytic leukemia (CLL) is a B cell disorder with multiple abnormalities in T-cell function. The status of the immune system will depend to some extent upon the net effect of the changes in the equilibrium of various hormones. In order to investigate the association of the defects in the cellular immunity and hormonal dysregulation in CLL, studies were performed in 130 CLL patients with that disorder. Decreased lymphocyte proliferation in response to mitogen stimulation appears to be an early event in CLL pathogenesis and is not always influenced by the clinical stage of the disease or the specific treatment. The dysfunction of T-lymphocytes was accompanied by increased serum cortisol (C) concentrations. Elevated levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), 17 beta-estradiol (E) and testosterone (T) ratio were found in male CLL patients, but not in female patients. In view of our findings, it is conceivable that there are a number of disturbances in the lymphocyte-microenvironmental regulation, which may be responsible for immuno-hormonal imbalance in some patients with CLL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338427     DOI: 10.3109/10428199209051031

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Effect of type II collagen extract on immunosuppression induced by methotrexate in rats.

Authors:  Ee-Hwa Kim; Yong-Min Kim; Jung-Ho Suh
Journal:  J Exerc Rehabil       Date:  2018-10-31

2.  Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Authors:  Eric P Allain; Karin Venzl; Patrick Caron; Véronique Turcotte; David Simonyan; Michaela Gruber; Trang Le; Eric Lévesque; Chantal Guillemette; Katrina Vanura
Journal:  Ann Hematol       Date:  2018-05-21       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.